Discover
RKDA
Arcadia Biosciences, Inc.
0.75
2 x 0.50
2 x 0.86
bid
ask
+
0.07
10.29%
2 @ 04:00 PM
0.69 -0.06 (8.41%)
| Ytd | -62.17% | |
| 1y | -83.09% |
0.63
day range
0.75
0.63
52 week range
6.71
| Open | 0.68 | Prev Close | 0.68 | Low | 0.63 | High | 0.75 | Mkt Cap | 1.54M |
| Vol | 154.20K | Avg Vol | 3.08M | EPS | -5.72 | P/E | N/A | Forward P/E | -4.76 |
| Beta | 1.27 | Short Ratio | 0.73 | Inst. Own | 4.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-19 | 50-d Avg | 0.96 | 200-d Avg | 2.31 | 1yr Est | 9.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | -0.77 | -0.87 | -0.1 | -12.99% |
| 2024-08-13 | 2024-06 | 1.27 | 0.78 | -0.49 | -38.58% |
| 2024-05-09 | 2024-03 | -2.52 | -1.78 | 0.74 | 29.37% |
| 2024-03-28 | 2023-12 | -2.68 | -2.48 | 0.2 | 7.46% |
| 2023-11-09 | 2023-09 | -2.67 | -1.83 | 0.84 | 31.46% |
| 2023-08-10 | 2023-06 | -4.92 | -2.64 | 2.28 | 46.34% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-08-21 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-05-23 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-04-05 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2023-08-28 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2023-07-24 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2023-06-05 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Profile
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-05-29 | JACOT STANLEY JR | Chief Executive Officer | 5.00K | Purchase |
| 2024-07-31 | KAWAKAMI MARK | Chief Financial Officer | 1.98K | Purchase |
| 2023-08-03 | SCHAEFER THOMAS J. | Chief Financial Officer | 719.00 | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Mariner, LLC | 25.00K | 152.25K | 1.83% |
| 2024-09-29 | Vanguard Group Inc | 14.04K | 85.49K | 1.03% |
| 2024-09-29 | State Street Corporation | 12.15K | 73.97K | 0.89% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 1.76K | 10.74K | 0.13% |
| 2024-09-29 | Morgan Stanley | 607.00 | 3.70K | 0.04% |
| 2024-09-29 | UBS Group AG | 239.00 | 1.46K | 0.02% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 14.04K | 85.49K | 1.03% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 7.58K | 46.14K | 0.56% |
| 2024-10-30 | Fidelity Total Market Index Fund | 1.63K | 9.90K | 0.12% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 1.01K | 6.13K | 0.07% |
Split
| Split | Date |
|---|---|
| 1 : 40 | 2023-03-01 |
| 1 : 20 | 2018-01-24 |